Skip to main content
Erschienen in: Internal and Emergency Medicine 1/2020

26.11.2019 | IM - REVIEW

Is there a link between venous and arterial thrombosis? A reappraisal

verfasst von: Paolo Prandoni

Erschienen in: Internal and Emergency Medicine | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Whether there is a link between venous and arterial thrombotic disorders is still a matter of debate. They share common risk factors, such as old age, male sex and obesity. Endothelial dysfunction and inflammation are likely to play a role in determining the simultaneous involvement of the two vascular compartments. Unlike subclinical atherosclerosis, symptomatic complications of atherosclerosis such as myocardial infarction, ischemic stroke and atrial fibrillation are likely to predict the subsequent development of venous thromboembolic (VTE) complications. Patients with VTE, especially those with apparently unprovoked episodes, have a definitely increased risk of subsequent arterial thrombotic disorders. Drugs that reduce the risk of arterial thrombosis are likely to reduce the risk of venous thrombosis and vice versa. In particular, the direct oral anticoagulants have recently been shown to reduce the risk of both vascular disorders. In conclusion, recent evidence provides compelling evidence in support of the link between venous and arterial thrombosis. Future studies are needed to clarify the nature of this association, to assess its extent, and to evaluate its implications for clinical practice.
Literatur
1.
Zurück zum Zitat Prandoni P, Bilora F, Marchiori A et al (2003) An association between atherosclerosis and venous thrombosis. N Engl J Med 348(15):1435–1441PubMedCrossRef Prandoni P, Bilora F, Marchiori A et al (2003) An association between atherosclerosis and venous thrombosis. N Engl J Med 348(15):1435–1441PubMedCrossRef
2.
Zurück zum Zitat Prandoni P, Piovella C, Pesavento R (2012) Venous thromboembolism and arterial complications. Semin Respir Crit Care Med 33(2):205–210PubMedCrossRef Prandoni P, Piovella C, Pesavento R (2012) Venous thromboembolism and arterial complications. Semin Respir Crit Care Med 33(2):205–210PubMedCrossRef
3.
Zurück zum Zitat Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117(1):93–102PubMedCrossRef Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117(1):93–102PubMedCrossRef
4.
Zurück zum Zitat Mahmoodi BK, Cushman M, Anne Næss I et al (2017) Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies. Circulation 135(1):7–16PubMedCrossRef Mahmoodi BK, Cushman M, Anne Næss I et al (2017) Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies. Circulation 135(1):7–16PubMedCrossRef
5.
Zurück zum Zitat Roshani S, Lijfering WM, Coppens M et al (2011) Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism. Neth J Med 69(1):27–30PubMed Roshani S, Lijfering WM, Coppens M et al (2011) Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism. Neth J Med 69(1):27–30PubMed
6.
Zurück zum Zitat Wattanakit K, Lutsey PL, Bell EJ et al (2012) Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost 108(3):508–515PubMedPubMedCentral Wattanakit K, Lutsey PL, Bell EJ et al (2012) Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost 108(3):508–515PubMedPubMedCentral
7.
Zurück zum Zitat Gregson J, Kaptoge S, Bolton T et al (2019) Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol 4(2):163–173PubMedCrossRef Gregson J, Kaptoge S, Bolton T et al (2019) Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol 4(2):163–173PubMedCrossRef
8.
Zurück zum Zitat Migliacci R, Becattini C, Pesavento R et al (2007) Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 92(6):812–818PubMedCrossRef Migliacci R, Becattini C, Pesavento R et al (2007) Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 92(6):812–818PubMedCrossRef
9.
Zurück zum Zitat Mahmoodi BK, Gansevoort RT, Veeger NJ et al (2009) Microalbuminuria and risk of venous thromboembolism. JAMA 301(17):1790–1797PubMedCrossRef Mahmoodi BK, Gansevoort RT, Veeger NJ et al (2009) Microalbuminuria and risk of venous thromboembolism. JAMA 301(17):1790–1797PubMedCrossRef
10.
Zurück zum Zitat Simes J, Robledo KP, White HD et al (2018) D-Dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease. Circulation 138(7):712–723PubMedCrossRef Simes J, Robledo KP, White HD et al (2018) D-Dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease. Circulation 138(7):712–723PubMedCrossRef
11.
Zurück zum Zitat Reich LM, Folsom AR, Key NS et al (2006) Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost 4(9):1909–1913PubMedCrossRef Reich LM, Folsom AR, Key NS et al (2006) Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost 4(9):1909–1913PubMedCrossRef
12.
Zurück zum Zitat van der Hagen PB, Folsom AR, Jenny NS et al (2006) Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 4(9):1903–1908PubMedCrossRef van der Hagen PB, Folsom AR, Jenny NS et al (2006) Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 4(9):1903–1908PubMedCrossRef
13.
Zurück zum Zitat Småbrekke B, Rinde LB, Hald EM et al (2017) Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study. J Thromb Haemost 15(12):2344–2351PubMedCrossRef Småbrekke B, Rinde LB, Hald EM et al (2017) Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study. J Thromb Haemost 15(12):2344–2351PubMedCrossRef
14.
Zurück zum Zitat Sørensen HT, Horvath-Puho E, Søgaard KK et al (2009) Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost 7(4):521–528PubMedCrossRef Sørensen HT, Horvath-Puho E, Søgaard KK et al (2009) Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost 7(4):521–528PubMedCrossRef
15.
Zurück zum Zitat Cavallari I, Morrow DA, Creager MA et al (2018) Frequency, predictors, and impact of combined antiplatelet therapy on venous thromboembolism in patients with symptomatic atherosclerosis. Circulation 137(7):684–692PubMedCrossRef Cavallari I, Morrow DA, Creager MA et al (2018) Frequency, predictors, and impact of combined antiplatelet therapy on venous thromboembolism in patients with symptomatic atherosclerosis. Circulation 137(7):684–692PubMedCrossRef
16.
Zurück zum Zitat Lutsey PL, Norby FL, Alonso A et al (2018) Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study. J Thromb Haemost 16(4):670–679PubMedPubMedCentralCrossRef Lutsey PL, Norby FL, Alonso A et al (2018) Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study. J Thromb Haemost 16(4):670–679PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Prandoni P, Ghirarduzzi A, Prins MH et al (2006) Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 4(9):1891–1896PubMedCrossRef Prandoni P, Ghirarduzzi A, Prins MH et al (2006) Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 4(9):1891–1896PubMedCrossRef
18.
Zurück zum Zitat Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P (2007) Venous thromboembolism and subsequent hospitalization due to acute arterial cardiovascular events—a 20 year cohort study. Lancet 370(9601):1773–1779PubMedCrossRef Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P (2007) Venous thromboembolism and subsequent hospitalization due to acute arterial cardiovascular events—a 20 year cohort study. Lancet 370(9601):1773–1779PubMedCrossRef
19.
Zurück zum Zitat Spencer FA, Ginsberg JS, Chong A, Alter DA (2008) The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction. J Thromb Haemost 6(9):1507–1513PubMed Spencer FA, Ginsberg JS, Chong A, Alter DA (2008) The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction. J Thromb Haemost 6(9):1507–1513PubMed
20.
Zurück zum Zitat Klok FA, Mos IC, Broek L et al (2009) Risk of arterial cardiovascular events in patients after pulmonary embolism. Blood 114(8):1484–1488PubMedCrossRef Klok FA, Mos IC, Broek L et al (2009) Risk of arterial cardiovascular events in patients after pulmonary embolism. Blood 114(8):1484–1488PubMedCrossRef
21.
Zurück zum Zitat Becattini C, Vedovati M, Ageno W, Dentali F, Agnelli G (2010) Incidence of arterial cardiovascular events after venous thromboembolism. A systematic review and a meta-analysis. J Thromb Haemost 8(5):891–897PubMed Becattini C, Vedovati M, Ageno W, Dentali F, Agnelli G (2010) Incidence of arterial cardiovascular events after venous thromboembolism. A systematic review and a meta-analysis. J Thromb Haemost 8(5):891–897PubMed
22.
Zurück zum Zitat Chang WT, Chang CL, Ho CH, Hong CS, Wang JJ, Chen ZC (2017) Long-term effects of unprovoked venous thromboembolism on mortality and major cardiovascular events. J Am Heart Assoc 6:e005466PubMedPubMedCentralCrossRef Chang WT, Chang CL, Ho CH, Hong CS, Wang JJ, Chen ZC (2017) Long-term effects of unprovoked venous thromboembolism on mortality and major cardiovascular events. J Am Heart Assoc 6:e005466PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Prandoni P, Lensing AW, Prins MH et al (2015) The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. Semin Thromb Hemost 41(2):133–140PubMedCrossRef Prandoni P, Lensing AW, Prins MH et al (2015) The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. Semin Thromb Hemost 41(2):133–140PubMedCrossRef
24.
Zurück zum Zitat Kunutsor SK, Seidu S, Khunti K (2017) Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematol 4(2):e83–e93PubMedCrossRef Kunutsor SK, Seidu S, Khunti K (2017) Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematol 4(2):e83–e93PubMedCrossRef
25.
Zurück zum Zitat Simes J, Becattini C, Agnelli G et al (2014) Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 130(13):1062–1071PubMedCrossRef Simes J, Becattini C, Agnelli G et al (2014) Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 130(13):1062–1071PubMedCrossRef
26.
Zurück zum Zitat Gibson CM, Chi G, Halaby R et al (2017) Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy. Circulation 135(7):648–655PubMedCrossRef Gibson CM, Chi G, Halaby R et al (2017) Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy. Circulation 135(7):648–655PubMedCrossRef
27.
Zurück zum Zitat Eikelboom JW, Connolly SJ, Bosch J et al (2017) Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 377(14):1319–1330PubMedCrossRef Eikelboom JW, Connolly SJ, Bosch J et al (2017) Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 377(14):1319–1330PubMedCrossRef
Metadaten
Titel
Is there a link between venous and arterial thrombosis? A reappraisal
verfasst von
Paolo Prandoni
Publikationsdatum
26.11.2019
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 1/2020
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02238-6

Weitere Artikel der Ausgabe 1/2020

Internal and Emergency Medicine 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.